131 iodine: Medical use. Carcinogenetic and genetic effects;Iode 131: Utilisation medicale. Effet cancerigenes et genetiques

Annales d'Endocrinologie

Volumn 57, Issue 3, 1996, Pages 166-176

  Schlumberger, M ^a   De Vathaire, F ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

131 iodine; carcinogenetic effects; genetic effects

Indexed keywords

IODINE 131; CARCINOGEN; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

CARCINOGENESIS; CONFERENCE PAPER; HUMAN; THYROID CARCINOMA; THYROTOXICOSIS; ADOLESCENT; ADULT; AGE; CHILD; FEMALE; HYPERTHYROIDISM; MALE; RADIATION ACCIDENT; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; REVIEW; THYROID TUMOR;

ACCIDENTS, RADIATION; ADOLESCENT; ADULT; AGE FACTORS; CARCINOGENS; CHILD; FEMALE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; NEOPLASMS, RADIATION-INDUCED; RADIATION DOSAGE; RADIATION GENETICS; THYROID NEOPLASMS;

EID: 0029763958     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. BOWLT C, TIPLADY P. Radioiodine in human thyroid glands and incidence of thyroid cancer in Cumbria. Br Med J 1989 ; 299 : 301-2.
2. BRINCKER H, HANSEN HS, ANDERSEN AP. Induction of leukaemia by 1311 treatment of thyroid carcinoma. Br J Cancer 1973 ; 28 : 232-7.
3. BROWN AP, GREENNING WP, MC CREADY VR, SHAW HJ, HARMER CL Radioiodine treatment of metastatic thyroid carcinoma : the Royal Marsden Hospital experience. Br J Radiol 1984 ; 57 : 523.
4. CASARA D, RUBELLO D, SALADINI G et al. Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer : potential risks and recommendations. Eur J Nucl Med 1993 , 20 : 192-4.
5. DOBYNS BM, SHELINE GE, WORKMAN JB, TOMPKINS EA, MC CONAHEY WM, BECKER DV. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism - a report of the cooperatibe thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab, 1974 ; 38 : 976-98.
6. DOBYNS BM, HYRMER BA. The surgical management of benign and malignant thyroid neoplasms in Marshall islanders exposed to hydrogen bomb fallout. World J Surg 1992 ; 16 : 126-40.
7. DOTTORINI ME, LOMUSCIO G, MAZZUCCHELLI L, VIGNATI A, COLOMBO L. Asseessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 1995 ; 36 , 21-7.
8. EDMONDS CJ, SMITH T. The long-term hazards of the treatment of thyroid cancer. Br J Radiol 1986 ; 59 : 45-51.
9. EINHORN J, HULTEN M, LINDSTEN J, WICKLUND H, ZETTERQUIST P. Clinical and cytogenic investigation in children of parents treated with radioiodine. Acta Radiol 1972 ; 11 : 193-208.
10. EMRICH D, CREUTZIG H. Benefits and risks of radioactive iodine therapy in differentiated thyroid carcinoma. Prog Surg 1988 ; 19 : 133-46.
11. FREITAS JE, SWANSON DP, GROSS MD, SISSON JC Iodine-131 : optimal therapy for hyperthyroidism in children and adolescents ? J Nucl Med 1979 ; 20 : 847-50.
12. GLOBEL B, GLÖBEL H, OBERHAUSEN E. Epidemiologic studies on patients with iodine-131 diagnostic and therapy. In : Kaul A., Neider R., Pensko J. et al., eds. Radiation Risk Protection, vol. II. International Radiation Protection Association. Köln : Fachverband für Strahlenschutz e.v. 1984 ; 565-8.
13. GOLDMAN MB, MALOOF F, MONSON RR, ASCHENGRALL A, COOPER DS, RIDGWAY EC. Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women. Am J Epidemiol 1988 ; 127 : 969-80.
14. HALL P, HOLM LE, LUNDELL G et al. Cancer risk in thyroid cancer patients. Br J Cancer 1991 ; 64 . 159-163
15. HALL P, BOICE JD, BERG G et al. Leukaemia incidence after iodine-131 exposure Lancet 1992 ; 340 : 1-4.
16. HANDELSMAN DJ, TURTLE JR. Testicular damage after radioactive iodine (I-131) therapy for thyroid cancer. Clin Endocrinol 1983 ; 118 : 465-72.
17. HAWKINS MM. Is there evidence of a therapy related increase in germ cell mutation among childhood cancer survivors ? J Natl Cancer Inst 1991 , 83 . 1643-50.
18. HAYEK A, CHAPMAN EM, CRAWFORD JD. Long-term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine. N Engl J Med 1970 ; 283 : 949-53.
19. HOFFMAN DA, MC CONAHEY WM, FRAUMENI JF JR, KURLAND LT. Cancer incidence following treatment of hyperthyroidism. In J Epidemiol 1982 ; 11 : 218-24.
20. HOFFMAN DA, MC CONAHEY WM. Breast cancer following iodine-131 therapy for hyperthyroidism J Natl Cancer Inst 1983 ; 70 : 63-7.
21. HOLM LE, DAHLQVIST I, ISRAELSSON A, LUNDELL G. Malignant thyroid tumors after iodine-131 therapy. N Engl J Med 1980 ; 303 : 188-91
22. HOLM LE. Carcinogenic and genetic risks of ionizing radiation with special reference to radioiodines. in : Thyroid Diseases. Beckers C., ed. Pergamon Press, 1982 ; 159-86.
23. HOLM LE. Malignant disease following iodine-131 therapy in Sweden. in : Radiation Carcinogenesis : Epidemiology and Biological Significance. Boice J.D. Jr, eds. Raven Press, New-York. 1984 ; 263-71.
24. HOLM LE, WIKLUND KE, LUNDELL GE et al. Thyroid cancer after diagnostic doses of iodine-131 : a retrospective cohort study. J Natl Cancer Inst 1988 ; 80 : 1132-8.
25. HOLM LE, WIKLUND KE, LUNDELL GE et al. Cancer risk a population examined with diagnostic doses of 131-1. J Natl Cancer Inst 1989 ; 81, 302-6.
26. HOLM LE, HALL P, WIKLUND K et al. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 1991 ; 83 : 1072-7.
27. KERBER RA, TILL JE, SIMON SL et al A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. JAMA 1993 ; 270 : 2076-82;
28. MAXON HR, THOMAS SR, HERTZBERG VS et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 1983 ; 309 : 937-41.
29. MIRD. MIRD primer for absorbed dose calculations. The Society of Nuclear Medicine. New-York, 1988.
30. MULVIHILL JJ, MYERS MH, CONNELLY RR et al. Cancer in offspring of long-term survivors of childhood and adolescent cancer. Lancet 1987 ; ii : 813-7.
31. National Council on Radiation Protection and Measurement. Induction of thyroid cancer by ionizing radiation. NCRP Report no 80, 1985.
32. PACINI F, GASPERI M, FUGAZZOLA L et al. Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine. J Nucl Med 1995 ; 35 : 1418-22.
33. POCHIN EE. Radioiodine therapy of thyroid cancer. Semin Nucl Med 1971 ; 1 : 503-15.
34. RAYMOND JP, IZEMBART M, MARLIAC V et al. Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine. J Clin Endocrinol Metab 1989 ; 69 : 186-90
35. RON E, LUBIN JH, SHORE RE et al. Thyroid cancer after exposure to external irradiation : a pooled analysis of seven studies. Radiat Res 1995 ; 141 : 259-77.
36. SAENGER EL, THOMA GE, TOMPKINS EA. Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the cooperative thyrotoxicosis therapy follow-up study. JAMA 1968 ; 205 : 147-54.
37. SAFA AM, SCHUMACHER OP, RODRIGUEZ-ANTUNEZ A. Long-term follow-up results in children and adolescents treated with radioactive iodine (I-131) for hyperthyroidism. N Engl J Med 1975 ; 292 167-71.
38. SAMAAN NA, SCHULTZ PN, ORDONEZ NG, HICKEY RC, JOHNSTON DA. Thyroid carcinoma in those who have and have not had head and neck irradiation in childhood. J Clin Endocrinol Metab 1987 , 64 : 219-23.
39. SARKAR SD, BEIERWALTES WH, GILL SP, COWLEY BJ. Subsequent fertility and birth histories of children and adolescents treated with 131-1 for thyroid cancer. J Nucl Med 1976 ; 17 : 460-4.
40. SCHLUMBERGER M, DE VATHAIRE F, TRAVAGLI JP et al. Differentiated thyroid carcinoma in childhood : long term follow-up of 72 patients. J Clin Endocrinol Metab 1987 , 65 : 1088-94.
41. SCHLUMBERGER M. Cancers de la thyroïde après Tchernobyl. Importance de la prophylaxie par le KI. Radioprotection 1994 , 29 : 397-404.
42. SCHLUMBERGER M, DE VATHAIRE F, CECCARELLI C et al. Exposure to radioiodine (I-131) for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 1996 ; 37 : 606-612.
43. SCHLUMBERGER M, CHALLETON C, DE VATHAIRE F et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from differentiated thyroid carcinoma J Nucl Med, 1996 ; 37 : 598-605
44. SCHNEIDER AB, RACANT W, PINSKY SM, RYO UY, BEKERMAN C, SHORE-FREEDMAN E. Radiation-induced thyroid carcinoma : clinical course and results of therapy in 296 patients. Ann Int Med 1986 ; 105 : 405-12.
45. SCHULL WJ, OTAKE M, NEEL JV. Genetic effects of the atomic bombs : a reappraisal. Science 1981 ; 213, 1220-7
46. SHORE RE. Issues and epidemiological evidence regarding radiation induced thyroid cancer. Radiat Res 1992 ; 31 : 98-111.
47. WINSHIP T, ROSVOLL RV. Thyroid carcinoma in childhood : final report on a 20 years study. Clinical Proceeding of the Children's Hospital of Washington. D.C. 1970 ; 26 : 327-48.
48. YOSHIMOTO Y. Cancer risk among children of atomic bomb survivors. A review of RERF epidemiologic studies. JAMA 1990 , 264 : 596-600